Zeroth W1, a humanoid robot developed by Lexiang Technology, is set to be unveiled at AWE 2026 in Shanghai, with the support of the Wall-E IP authorization from the Disney animated film. The Beijing-based company has recently secured significant investment from Ant Group, which led a 500 million yuan ($73.58 million) funding round. This investment marks Ant’s twelfth venture into the humanoid robotics sector since early 2025, as the organization expands its technological footprint following a halted IPO in 2020.
Ant Group, a subsidiary of Alibaba, has diversified its portfolio, investing in various robotics firms, including Galaxea and Unitree, as well as software and component providers such as Linkerbot and Genrobot AI. In recent years, Ant has launched a healthcare services application and has established a humanoid robot subsidiary, RobbyAnt, which is focused on developing intelligent robotics solutions.
Zeroth’s founder, Guo Renjie, indicated that the company aims to develop robots tailored for home environments, beginning with models designed for elderly companionship and pet care, and eventually moving into educational robots for children. The start-up has reportedly secured over 30,000 orders and experienced a dramatic 600% increase in operating revenue in the first half of the year. Plans are in place to expand overseas, with potential sales beginning in North America and Europe as soon as compliance regulations are met.
This surge in investment and interest in humanoid robotics coincides with broader trends in the technology sector, as evidenced by recent job postings by Nvidia in major Chinese cities.
Why this story matters
- Highlights growing investment in humanoid robotics, signaling increased interest in automation and AI in everyday life.
Key takeaway
- Zeroth’s innovation and strategic investments point to a rapid evolution in the humanoid robot market, particularly in China.
Opposing viewpoint
- Some industry experts caution that the rapid development of humanoid robots may outpace regulatory measures and ethical considerations surrounding their use.
